The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Encephalitis Vaccination Market Research Report 2024
Synopsis
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
The global Encephalitis Vaccination market was valued at US$ 1291.2 million in 2023 and is anticipated to reach US$ 1899.3 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
This report aims to provide a comprehensive presentation of the global market for Encephalitis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Encephalitis Vaccination.
Report Scope
The Encephalitis Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Encephalitis Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Encephalitis Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Beijing Taitan
Valneva
Bharat Biotech
Liaoning Chengda
Segment by Type
Encephalitis B Vaccine
Encephalitis Attenuated Live Vaccine
Segment by Application
Public Hospital
Private Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Encephalitis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
The global Encephalitis Vaccination market was valued at US$ 1291.2 million in 2023 and is anticipated to reach US$ 1899.3 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
This report aims to provide a comprehensive presentation of the global market for Encephalitis Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Encephalitis Vaccination.
Report Scope
The Encephalitis Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Encephalitis Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Encephalitis Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sanofi
Chengdu Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Beijing Taitan
Valneva
Bharat Biotech
Liaoning Chengda
Segment by Type
Encephalitis B Vaccine
Encephalitis Attenuated Live Vaccine
Segment by Application
Public Hospital
Private Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Encephalitis Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Encephalitis Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Encephalitis Vaccination Market Overview
1.1 Product Overview and Scope of Encephalitis Vaccination
1.2 Encephalitis Vaccination Segment by Type
1.2.1 Global Encephalitis Vaccination Market Value Comparison by Type (2024-2030)
1.2.2 Encephalitis B Vaccine
1.2.3 Encephalitis Attenuated Live Vaccine
1.3 Encephalitis Vaccination Segment by Application
1.3.1 Global Encephalitis Vaccination Market Value by Application: (2024-2030)
1.3.2 Public Hospital
1.3.3 Private Hospital
1.3.4 Clinic
1.3.5 Other
1.4 Global Encephalitis Vaccination Market Size Estimates and Forecasts
1.4.1 Global Encephalitis Vaccination Revenue 2019-2030
1.4.2 Global Encephalitis Vaccination Sales 2019-2030
1.4.3 Global Encephalitis Vaccination Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Encephalitis Vaccination Market Competition by Manufacturers
2.1 Global Encephalitis Vaccination Sales Market Share by Manufacturers (2019-2024)
2.2 Global Encephalitis Vaccination Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Encephalitis Vaccination Average Price by Manufacturers (2019-2024)
2.4 Global Encephalitis Vaccination Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Encephalitis Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Encephalitis Vaccination, Product Type & Application
2.7 Encephalitis Vaccination Market Competitive Situation and Trends
2.7.1 Encephalitis Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Encephalitis Vaccination Players Market Share by Revenue
2.7.3 Global Encephalitis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Encephalitis Vaccination Retrospective Market Scenario by Region
3.1 Global Encephalitis Vaccination Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Encephalitis Vaccination Global Encephalitis Vaccination Sales by Region: 2019-2030
3.2.1 Global Encephalitis Vaccination Sales by Region: 2019-2024
3.2.2 Global Encephalitis Vaccination Sales by Region: 2025-2030
3.3 Global Encephalitis Vaccination Global Encephalitis Vaccination Revenue by Region: 2019-2030
3.3.1 Global Encephalitis Vaccination Revenue by Region: 2019-2024
3.3.2 Global Encephalitis Vaccination Revenue by Region: 2025-2030
3.4 North America Encephalitis Vaccination Market Facts & Figures by Country
3.4.1 North America Encephalitis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Encephalitis Vaccination Sales by Country (2019-2030)
3.4.3 North America Encephalitis Vaccination Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Encephalitis Vaccination Market Facts & Figures by Country
3.5.1 Europe Encephalitis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Encephalitis Vaccination Sales by Country (2019-2030)
3.5.3 Europe Encephalitis Vaccination Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Encephalitis Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific Encephalitis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Encephalitis Vaccination Sales by Country (2019-2030)
3.6.3 Asia Pacific Encephalitis Vaccination Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Encephalitis Vaccination Market Facts & Figures by Country
3.7.1 Latin America Encephalitis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Encephalitis Vaccination Sales by Country (2019-2030)
3.7.3 Latin America Encephalitis Vaccination Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Encephalitis Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Encephalitis Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Encephalitis Vaccination Sales by Country (2019-2030)
3.8.3 Middle East and Africa Encephalitis Vaccination Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Encephalitis Vaccination Sales by Type (2019-2030)
4.1.1 Global Encephalitis Vaccination Sales by Type (2019-2024)
4.1.2 Global Encephalitis Vaccination Sales by Type (2025-2030)
4.1.3 Global Encephalitis Vaccination Sales Market Share by Type (2019-2030)
4.2 Global Encephalitis Vaccination Revenue by Type (2019-2030)
4.2.1 Global Encephalitis Vaccination Revenue by Type (2019-2024)
4.2.2 Global Encephalitis Vaccination Revenue by Type (2025-2030)
4.2.3 Global Encephalitis Vaccination Revenue Market Share by Type (2019-2030)
4.3 Global Encephalitis Vaccination Price by Type (2019-2030)
5 Segment by Application
5.1 Global Encephalitis Vaccination Sales by Application (2019-2030)
5.1.1 Global Encephalitis Vaccination Sales by Application (2019-2024)
5.1.2 Global Encephalitis Vaccination Sales by Application (2025-2030)
5.1.3 Global Encephalitis Vaccination Sales Market Share by Application (2019-2030)
5.2 Global Encephalitis Vaccination Revenue by Application (2019-2030)
5.2.1 Global Encephalitis Vaccination Revenue by Application (2019-2024)
5.2.2 Global Encephalitis Vaccination Revenue by Application (2025-2030)
5.2.3 Global Encephalitis Vaccination Revenue Market Share by Application (2019-2030)
5.3 Global Encephalitis Vaccination Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Encephalitis Vaccination Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Encephalitis Vaccination Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Chengdu Institute of Biological Products
6.3.1 Chengdu Institute of Biological Products Corporation Information
6.3.2 Chengdu Institute of Biological Products Description and Business Overview
6.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolio
6.3.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.4 Wuhan Institute of Biological Products
6.4.1 Wuhan Institute of Biological Products Corporation Information
6.4.2 Wuhan Institute of Biological Products Description and Business Overview
6.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolio
6.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.5 Lanzhou Institute of Biological Products
6.5.1 Lanzhou Institute of Biological Products Corporation Information
6.5.2 Lanzhou Institute of Biological Products Description and Business Overview
6.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolio
6.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.6 Beijing Taitan
6.6.1 Beijing Taitan Corporation Information
6.6.2 Beijing Taitan Description and Business Overview
6.6.3 Beijing Taitan Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Beijing Taitan Encephalitis Vaccination Product Portfolio
6.6.5 Beijing Taitan Recent Developments/Updates
6.7 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Valneva Encephalitis Vaccination Product Portfolio
6.7.5 Valneva Recent Developments/Updates
6.8 Bharat Biotech
6.8.1 Bharat Biotech Corporation Information
6.8.2 Bharat Biotech Description and Business Overview
6.8.3 Bharat Biotech Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bharat Biotech Encephalitis Vaccination Product Portfolio
6.8.5 Bharat Biotech Recent Developments/Updates
6.9 Liaoning Chengda
6.9.1 Liaoning Chengda Corporation Information
6.9.2 Liaoning Chengda Description and Business Overview
6.9.3 Liaoning Chengda Encephalitis Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Liaoning Chengda Encephalitis Vaccination Product Portfolio
6.9.5 Liaoning Chengda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Encephalitis Vaccination Industry Chain Analysis
7.2 Encephalitis Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Encephalitis Vaccination Production Mode & Process
7.4 Encephalitis Vaccination Sales and Marketing
7.4.1 Encephalitis Vaccination Sales Channels
7.4.2 Encephalitis Vaccination Distributors
7.5 Encephalitis Vaccination Customers
8 Encephalitis Vaccination Market Dynamics
8.1 Encephalitis Vaccination Industry Trends
8.2 Encephalitis Vaccination Market Drivers
8.3 Encephalitis Vaccination Market Challenges
8.4 Encephalitis Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
